Clinical and translational science · 2013
Cytokine profiling in patients with VCP-associated disease.
СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dec Eric, Rana Prachi, Katheria Veeral, Dec Rachel, Khare Manaswitha, Nalbandian Angèle, Leu Szu-Yun, Radom-Aizik Shlomit, Llewellyn Katrina, BenMohamed Lbachir, Zaldivar Frank, Kimonis Virginia
Аннотация
Valosin containing protein (VCP) disease (also known as Inclusion Body Myopathy, Paget Disease of Bone and Frontotemporal Dementia [IBMPFD] syndrome) is caused by mutations in the gene encoding VCP classically affecting the muscle, bone and brain. Although the genetic cause has been identified, details regarding the pathogenesis of IBMPFD have not been fully determined. Muscle wasting observed in VCP disease is suggestive of cytokine imbalance. We hypothesized that dysfunctional protein homeostasis caused by VCP mutations leads to cytokine imbalances thereby contributing to the muscle wasting phenotype. Circulating levels of interleukin-4 (IL-4), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF a) and epidermal growth factor (EGF) were measured in plasma of patients with VCP disease or controls. TNF a and EGF were significantly altered in VCP disease as compared to control. TNF a was up-regulated, consistent with a cachexia phenotype and EGF levels were increased. No significant differences were observed in IL-4 and IL-6. Cytokine imbalances may be associated with VCP disease and may play a contributory role in VCP myopathy. Further understanding of how VCP dysfunction leads to aberrant protein homeostasis and subsequent cytokine imbalances may also aid in the understanding of other proteinopathies and in the development of novel treatments.
Предметные рубрики MeSH
Adenosine TriphosphatasesCase-Control StudiesCell Cycle ProteinsCytokinesEpidermal Growth FactorFrontotemporal DementiaHumansInterleukin-4Interleukin-6Muscle DevelopmentMuscular AtrophyMuscular Dystrophies, Limb-GirdleMutationMyositis, Inclusion BodyOsteitis DeformansSignal TransductionSyndromeTumor Necrosis Factor-alphaValosin Containing Protein